Innovations in multi-parameter cell based assays, following 20 years of R&D, to develop fundamental new ways to measure platelet function in clinical trials, diagnostics and research.
Our technology uses multiparameter platelet function analysis to transform:
Today
The Sunday Times wrote about TRIPLEcheck, a simple blood test, that could lead to smarter prescribing of treatments for heart attack and stroke patients.
15 Jul 2026
HaemAnalytica won two awards at the Thames Valley Innovation and Tech Awards 2026 — Innovative Tech of the Year and Tech Start-up of the Year — recognised for cutting-edge research underpinning scalable medical technology with measurable patient outcomes.
Multi-parameter assays and AI-based phenotyping, enabling insightful platelet analysis to de-risk clinical trials and enhance drug development.
Registered in England, company number 15921838
Web design by Tribal Systems, built on Zenario
Sorry, this form requires you to accept Analytics and Functional cookies before it can load. Click here to allow these types of cookie.